FAQ

prostaglandin-inositol cyclic phosphate

Known as: cPIP, prostaglandyl-inositol cyclic phosphate, prostaglandylinositol cyclic phosphate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2016
012319872016

Related topics

Related topics

2 relations

Broader (2)

Inositol PhosphatesProstaglandins E

Related mentions per year

Related mentions per year

1959-2018
1960198020002020
prostaglandin-inositol cyclic phosphate
Prostaglandins E
Inositol Phosphates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Groin Pain After Inguinal Hernia Repair.
Quality of life and avoidance of chronic postoperative inguinal pain (CPIP) are now primary outcomes of elective inguinal… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2000
2000
Phosphatidylinositol 3-kinase and prostaglandylinositol cyclic phosphate (cyclic PIP), a mediator of insulin action, in the signal transduction of insulin.
It has been suggested that downstream signaling from the insulin receptor to the level of the protein kinases and protein… (More)
Is this relevant?
2000
2000
Prostaglandin deficiency promotes sensitization of adenylyl cyclase.
Inhibition of prostaglandin synthesis by the drug indomethacin suppresses the synthesis of the cyclic AMP antagonist… (More)
Is this relevant?
1999
1999
Degradation of the cyclic AMP antagonist prostaglandylinositol cyclic phosphate (cyclic PIP) by dephosphorylation.
The cAMP antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), is synthesized from prostaglandin E and activated… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1998
1998
Synthesis and action of the cyclic AMP antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), in Dictyostelium discoideum.
The cyclic AMP antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), is synthesized from prostaglandin E (PGE) and… (More)
Is this relevant?
1997
1997
Insulin resistance, a result of reduced synthesis of prostaglandylinositol cyclic phosphate, a mediator of insulin action? Regulation of cyclic PIP synthetase activity by oral antidiabetic and…
Reduced ability or failure to stimulate cyclic adenosinemonophosphate (AMP) synthesis on a second addition of hormone 30 min… (More)
Is this relevant?
1996
1996
Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat…
The endogenous cyclic adenosine monophosphate (AMP) antagonist, cyclic PIP, has been identified as a prostaglandylinositol cyclic… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1994
1994
Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanisms of insulin action
Glucose tolerance tests in rats showed that after indomethacin treatment plasma insulin levels rose five-fold higher than in… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • table 1
Is this relevant?
1993
1993
The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone-stimulated synthesis and identification as prostaglandylinositol cyclic phosphate
This report shows that the cyclic AMP antagonist cyclic PIP is present in all organs and tissues of the rat so far examined… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1987
1987
Prostaglandylinositol cyclic phosphate, an antagonist to cyclic AMP.
The existence of a low molecular weight intracellular regulator has been demonstrated. It is composed of PGE, myoinositol, and… (More)
Is this relevant?